Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes.

Oved, Joseph H; Babushok, Daria V; Lambert, Michele P; Wolfset, Nicole; Kowalska, M Anna; Poncz, Mortimer; Karczewski, Konrad J; Olson, Timothy S

Oved, Joseph H; Babushok, Daria V; Lambert, Michele P; Wolfset, Nicole; Kowalska, M Anna; Poncz, Mortimer; Karczewski, Konrad J; Olson, Timothy S.

Affiliation

Oved JH; Division of Hematology, Department of Pediatrics.
Babushok DV; Comprehensive Bone Marrow Failure Center, Division of Hematology, and.
Lambert MP; Cell Therapy & Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.
Wolfset N; Comprehensive Bone Marrow Failure Center, Division of Hematology, and.
Kowalska MA; Division of Hematology-Oncology, Hospital of University of Pennsylvania, Philadelphia, PA.
Poncz M; Division of Hematology, Department of Pediatrics.
Karczewski KJ; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Olson TS; Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

Blood Adv ; 4(20): 5232-5245, 2020 10 27.

Article de En | MEDLINE | ID: mdl-33104793

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndromes myélodysplasiques Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Blood Adv Année: 2020 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google